A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis — a new wave of scrutiny of the high cost of its insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback